PubRank

L Frattola

Author PubWeight™ 59.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc 1993 2.02
2 Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001 1.54
3 Effects of sensory aids on the quality of life and mortality of elderly people: a multivariate analysis. Age Ageing 1996 1.43
4 Elevated glutamate in the cerebrospinal fluid of patients with HIV dementia. JAMA 1997 1.41
5 Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke. J Neurosci Res 1984 1.35
6 Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999 1.23
7 Sensory impairments and mortality in an elderly community population: a six-year follow-up study. Age Ageing 1995 1.07
8 Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 1999 1.05
9 Carboplatin toxic effects on the peripheral nervous system of the rat. Ann Oncol 1998 1.05
10 Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene. Neurology 2000 1.01
11 Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 1993 0.92
12 Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. Br J Clin Pract Suppl 1984 0.91
13 The metabolism of cyclic-3'-5'-adenosine monophosphate (cAMP) in diseased muscle. J Neurol 1975 0.90
14 Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases. Neurol Sci 2004 0.90
15 Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res 1998 0.88
16 Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett 2000 0.88
17 Effects of bromocriptine on central dopaminergic receptors. Life Sci 1976 0.86
18 Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 1993 0.86
19 Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp Neurol 1999 0.86
20 Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr Scand 1990 0.86
21 Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001 0.85
22 Cognitive [correction of cognitve] estimation: comparison of two tests in nondemented parkinsonian patients. Neurol Sci 2003 0.84
23 Reduced platelet glutamate uptake in Parkinson's disease. J Neural Transm (Vienna) 1999 0.83
24 Treatment of Huntington's chorea with bromocriptine. Acta Neurol Scand 1977 0.83
25 Physical anhedonia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003 0.83
26 Benzodiazepine-induced chemotaxis is impaired in monocytes from patients with generalized anxiety disorder. Psychoneuroendocrinology 1999 0.83
27 Hemiparkinsonism. A human model for studying dopaminergic supersensitivity. Arch Neurol 1979 0.81
28 Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia. Neurology 1990 0.81
29 Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis. Neurol Sci 2006 0.81
30 Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors. Ann Neurol 1989 0.81
31 Characterization of peripheral benzodiazepine receptors in human blood mononuclear cells. Neuropharmacology 1990 0.80
32 Basal, cAMP- and cGMP-dependent protein kinases in human brain tumors. Acta Neurol Scand 1979 0.80
33 Distribution of a putative endogenous modulator of the GABAergic system in human brain. Neurology 1989 0.79
34 Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland. Psychopharmacology (Berl) 1991 0.79
35 Central nervous system involvement in elderly patients with non-insulin-dependent diabetes mellitus. Acta Diabetol Lat 1991 0.79
36 Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease. Neurol Sci 2001 0.79
37 Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients. Anticancer Res 1999 0.78
38 Screening cognitive decline in dementia: preliminary data on the Italian version of the IQCODE. Neurol Sci 2002 0.78
39 Nerve growth factor and transforming growth factor-beta serum levels in acute stroke patients. Possible involvement of neurotrophins in cerebrovascular disease. Cerebrovasc Dis 2001 0.78
40 Skeletal muscle glycogenosis type II: biochemical and electron microscopic investigations of one case. Z Neurol 1972 0.78
41 Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann Neurol 2000 0.78
42 Effects of a MAO-B inhibitor in the treatment of Alzheimer disease. Eur Neurol 1991 0.78
43 Monosialoganglioside therapy in stroke. Stroke 1985 0.78
44 Treatment of denervated muscle by gangliosides. Muscle Nerve 1979 0.78
45 Metabolism of cyclic nucleotides in healthy and diseased human muscle. Isr J Med Sci 1977 0.78
46 [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients]. Nouv Presse Med 1976 0.78
47 "On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment. Acta Neurol Scand 1982 0.78
48 Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione. Ital J Neurol Sci 1992 0.78
49 Antiepileptic drugs and peripheral nerve function: a multicenter screening investigation of 141 patients with chronic treatment. Collaborative Group for the Study of Epilepsy. Epilepsia 1993 0.78
50 Chronic cerebrovascular disorders: a clinical study with cyclandelate. Br J Clin Pract 1984 0.78
51 Effect of common carotid occlusion on beta-adrenergic receptor function in cerebral microvessels. Stroke 1985 0.77
52 Acute treatment of Huntington's chorea with lisuride. J Neurol Sci 1983 0.77
53 Multiple forms of protein kinase from normal human brain and glioblastoma. Cancer Res 1983 0.77
54 Decrease in phorbol ester receptors in human brain tumors. Eur Neurol 1990 0.77
55 Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biol Regul Homeost Agents 2004 0.77
56 Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. J Neurol 2001 0.77
57 Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis. Int J Tissue React 2001 0.77
58 Characterization of the gamma-aminobutyric acid receptor system in human brain gliomas. Cancer Res 1985 0.77
59 Lisuride in generalised dystonia and spasmodic torticollis. Lancet 1982 0.77
60 Assessing clinically relevant cognitive decline: preliminary data on a new method. Neurol Sci 2003 0.77
61 Characterization of beta-adrenergic receptors on human cerebral microvessels. Neurology 1982 0.76
62 Encephalomyelitis with thyrotoxicosis. J Neurol 1978 0.76
63 Which diagnostic procedures in the elderly? The case of late-onset Huntington's disease. J Geriatr Psychiatry Neurol 1997 0.76
64 Regulation of the cyclic guanosine 3'-5' monophosphate system in human brain tumors. Acta Neurol Scand 1976 0.76
65 Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients. Ital J Neurol Sci 1996 0.76
66 Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: effect of nocturnal assisted ventilation. J Neurol 1998 0.76
67 Glial brain tumors lack microvascular adrenergic receptors. Eur Neurol 1988 0.76
68 Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy. Arch Neurol 1982 0.76
69 Chronic axonal sensory and autonomic polyneuropathy without motor involvement: a new 'chronic inflammatory neuropathy?'. Eur J Neurol 1999 0.76
70 Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study. Acta Neurol Scand 2000 0.76
71 Guanylate cyclase in human brain tumors: regulation of cellular growth. Pharmacol Res Commun 1977 0.76
72 Risk factors for the development of severe cisplatin neurotoxicity. Int J Oncol 1997 0.75
73 Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides. Muscle Nerve 1982 0.75
74 Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placebo. Acta Neurol Scand 1996 0.75
75 Motor behaviour modifications after a stroke in a patient with Huntington's disease. J Neurol Neurosurg Psychiatry 1984 0.75
76 The eyes and ears of the world of function. J Am Geriatr Soc 1989 0.75
77 Guanylate cyclase activity in normal and diseased human muscle. J Neurol Neurosurg Psychiatry 1978 0.75
78 Trial of ganglioside GM1 in acute stroke. J Neurol Neurosurg Psychiatry 1989 0.75
79 Dopamine receptors and sleep induction in man. J Neurol Neurosurg Psychiatry 1979 0.75
80 Lisuride in extrapyramidal disorders: a possible mechanism of action. Adv Neurol 1984 0.75
81 Dihydroergokryptine vs. placebo in dementia of Alzheimer type: interim results of a randomized multicenter study after a 1-year follow-up. Arch Gerontol Geriatr 2004 0.75
82 Rational use of EEG in adults in clinical practice. J Clin Neurophysiol 1999 0.75
83 Calmodulin content in human brain tumors. J Neurol Sci 1987 0.75
84 Cognitive assessment of severe dementia: the test for severe impairment (TSI). Arch Gerontol Geriatr Suppl 2001 0.75
85 Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia. Drugs 1987 0.75
86 Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric stroke. Acta Neurol Scand 1986 0.75
87 Effect of exercise and denervation on glycogen synthetase of skeletal muscle. Med Exp Int J Exp Med 1968 0.75
88 Characterization of protein kinase system in human skeletal muscle. J Neurol Sci 1980 0.75
89 [Glycide interconversion in normal human muscle tissue and under various atrophic conditions]. Riv Patol Nerv Ment 1966 0.75
90 Time-related asymmetric changes of brain microvessel beta-adrenergic receptors in the two hemispheres after carotid occlusion. Stroke 1986 0.75
91 Physiologic study of the subthalamic volume. Neurol Sci 2001 0.75
92 The system of cyclic nucleotides in the growth regulation of cerebral tumors in the young. Mod Probl Paediatr 1978 0.75
93 Lipid changes in neurogenic muscular atrophies. Res Exp Med (Berl) 1974 0.75
94 Treatment of Parkinson's disease with proglumide, a CCK antagonist. Neurology 1991 0.75
95 Bromocriptine and Huntington's chorea. Arch Neurol 1978 0.75
96 Biochemical and morphological changes induced by triton-X 100 in skeletal muscle of rats after abdominal aorta ligation. Experientia 1973 0.75
97 [Modifications in the structure and course of cyclothymic depressions which digress from the formal schizophrenic picture]. Riv Patol Nerv Ment 1965 0.75
98 Choline acetyltransferase activity in human muscular diseases. J Neurol 1976 0.75
99 On the role of cyclic nucleotides in tumor of human nervous tissue: an overview. J Neurosurg Sci 1980 0.75
100 Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea. Eur Neurol 1995 0.75
101 Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease. Adv Neurol 1990 0.75
102 Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects. Adv Biochem Psychopharmacol 1980 0.75
103 The effect of serotonin on skeletal muscle of dehydrotachysterol-sensitized rats: an electron microscopic study. Arch Int Pharmacodyn Ther 1972 0.75
104 A case of lipid storage myopathy with carnitine deficiency. Biochemical and electromyographic correlations. Eur Neurol 1977 0.75
105 Therapeutic experience with transdihydrolisuride in Huntington's disease. Neurology 1986 0.75
106 Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients. Clin Neuropharmacol 1989 0.75
107 [Possible involvement of dopaminergic mechanisms in the action of tranquilizing agents]. Acta Neurol (Napoli) 1977 0.75
108 Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases. Adv Biochem Psychopharmacol 1977 0.75
109 [Glucide interconversion and glycogen synthesis by uridine-diphosphoglucose (UDPG), in cerebral tumors]. Minerva Neurochir 1965 0.75
110 Image generation from long-term memory in Parkinson's disease. Adv Neurol 1996 0.75
111 Changes in muscular glycogen synthetase activity following denervation. Nature 1966 0.75
112 [Guanyl cyclase and cyclic guanosine 3',5'-monosphate-phosphodiesterase in human cerebral tumors]. Acta Neurol (Napoli) 1976 0.75
113 Alcoholic hyperlipidaemia. Lancet 1972 0.75
114 Cyclic nucleotides in human cerebral tumors: role of the protein kinase system. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984 0.75
115 Characteristics of the cyclic AMP-phosphodiesterase activator in human brain tumours. J Neurol Sci 1982 0.75
116 [Polygraphic study during spontaneous nocturnal sleep in a case of bulbar myoclonus]. Riv Neurol 1971 0.75
117 Listeria rhombencephalitis: report of two cases with early diagnosis and favourable outcome. Clin Neurol Neurosurg 1995 0.75
118 An investigation of the effect on platelet function of acetylsalicylic acid, dipyridamole and the two drugs in combination in patients with transient attacks of ischaemia. J Int Med Res 1979 0.75
119 Metabolic and morphologic changes induced by serotonin in skeletal muscle of rats after abdominal aorta ligation. J Med 1983 0.75
120 Stimulation of lymphocytes by cholinergic receptor in myasthenia gravis. J Neuropathol Exp Neurol 1977 0.75
121 [Chronic copper poisoning in rats: biochemical and histochemical changes in the brain and liver]. Acta Neurol (Napoli) 1971 0.75
122 Effect of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes. Neuropharmacology 1995 0.75
123 Adenyl cyclase and phosphodiesterase in human cerebral tumors. J Neurosurg Sci 1975 0.75
124 Decreased density of lymphocyte benzodiazepine receptors in drug-resistant epileptic patients. Epilepsy Res 1997 0.75
125 Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa. Br J Clin Pract 1986 0.75
126 Cyclic nucleotide phosphodiesterase activity in muscle of patients with carcinoma. J Neurol Sci 1979 0.75